Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:00AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.28B |
| Enterprise Value | 1.12B |
| Trailing P/E | 23.58 |
| Forward P/E | 26.67 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.66 |
| Price/Book (mrq) | 1.83 |
| Enterprise Value/Revenue | 8.52 |
| Enterprise Value/EBITDA | 11.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.92 |
| 52-Week Change 3 | -6.90% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 94.57 |
| 52 Week Low 3 | 49.24 |
| 50-Day Moving Average 3 | 74.58 |
| 200-Day Moving Average 3 | 66.96 |
Share Statistics
| Avg Vol (3 month) 3 | 179.9k |
| Avg Vol (10 day) 3 | 144k |
| Shares Outstanding 5 | 17.96M |
| Implied Shares Outstanding 6 | 17.71M |
| Float 8 | 17.35M |
| % Held by Insiders 1 | 2.43% |
| % Held by Institutions 1 | 94.12% |
| Shares Short (Apr 15, 2024) 4 | 826.61k |
| Short Ratio (Apr 15, 2024) 4 | 4.18 |
| Short % of Float (Apr 15, 2024) 4 | 6.82% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 4.67% |
| Shares Short (prior month Mar 15, 2024) 4 | 876.3k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Jul 02, 2010 |
| Last Split Factor 2 | 1603:1000 |
| Last Split Date 3 | Nov 02, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 39.72% |
| Operating Margin (ttm) | -11.95% |
Management Effectiveness
| Return on Assets (ttm) | 0.79% |
| Return on Equity (ttm) | 8.29% |
Income Statement
| Revenue (ttm) | 131.31M |
| Revenue Per Share (ttm) | 7.59 |
| Quarterly Revenue Growth (yoy) | -44.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | 45.46M |
| Net Income Avi to Common (ttm) | 53.82M |
| Diluted EPS (ttm) | 3.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 170.31M |
| Total Cash Per Share (mrq) | 9.62 |
| Total Debt (mrq) | 6.18M |
| Total Debt/Equity (mrq) | 0.88% |
| Current Ratio (mrq) | 14.15 |
| Book Value Per Share (mrq) | 39.92 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 49.58M |
| Levered Free Cash Flow (ttm) | -4.76M |
© 2024 Yahoo. All rights reserved.